196 related articles for article (PubMed ID: 14436429)
1. [Clinical experiences with segontin].
RATSCHOW M; SCHOOP W
Med Klin; 1960 Aug; 55():1421-3. PubMed ID: 14436429
[No Abstract] [Full Text] [Related]
2. [Experiences with the clinical use of Segontin in coronary disease].
OHIRA I; HAGIWARA M; UMEZONO T; TSUCHIYA T; IMAGAWA S; MATSUOKA K
Chiryo; 1962 Aug; 44():1573-7. PubMed ID: 14481363
[No Abstract] [Full Text] [Related]
3. [Experiences with segontin in internal medical practice].
MENZEL M
Ther Ggw; 1960 Sep; 99():432-4. PubMed ID: 13769511
[No Abstract] [Full Text] [Related]
4. [A double-blind experiment with the coronary therapeutic agent segontin].
OVERKAMP H
Med Klin; 1960 Aug; 55():1423-6. PubMed ID: 14429518
[No Abstract] [Full Text] [Related]
5. [Treatment of coronary circulatory disorders in internal practice with segontin].
HAMANN E
Landarzt; 1961 Nov; 37():1277-9. PubMed ID: 13904049
[No Abstract] [Full Text] [Related]
6. [3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine.] (Segontin) in syndromes of coronary insufficiency. Preliminary note].
DELLA PORTA P; LUCCHINI CR
Minerva Cardioangiol; 1961 Sep; 9():533-6. PubMed ID: 13885183
[No Abstract] [Full Text] [Related]
7. [Criteria of the efficacy of the treatment of coronary disease: "the coronary vasodilators"].
CLOAREC M
Sem Hop Ther Paris; 1961 Oct; 37():753-4. PubMed ID: 13879970
[No Abstract] [Full Text] [Related]
8. [Preliminary results in the treatment of coronary disease with segotonin].
NEDELJKOVIC S; DORDEVIC BS
Med Glas; 1961; 15():400-2. PubMed ID: 14478728
[No Abstract] [Full Text] [Related]
9. [Clinical and experimental studies on persantin in coronary diseases].
GREIF S
Wien Med Wochenschr; 1960 Jun; 110():463-6. PubMed ID: 13851721
[No Abstract] [Full Text] [Related]
10. [Considerations on the use of a new pharmacological association in the treatment of coronary disease].
ZOTTI G; ZOTTI E
Gazz Med Ital; 1960 Nov; 119():453-66. PubMed ID: 13788819
[No Abstract] [Full Text] [Related]
11. Studies with a new coronary vasodilator drug: persantin.
KINSELLA D; TROUP W; McGREGOR M
Am Heart J; 1962 Feb; 63():146-51. PubMed ID: 14456202
[No Abstract] [Full Text] [Related]
12. [Results of a clinico-instrumental observation in the course of treatment with a new coronary dilator agent].
MENTASTI GE; FANCINI P
Minerva Cardioangiol; 1962 Mar; 10():197-205. PubMed ID: 14472699
[No Abstract] [Full Text] [Related]
13. [On the therapy of coronary insufficiency].
DUETSCH L
Ther Ggw; 1960 May; 99():228-34. PubMed ID: 13818454
[No Abstract] [Full Text] [Related]
14. [A contribution to the therapy of coronary insufficiency].
LEIMGARDT H
Medizinische; 1959 Dec; No 49():2408-12. PubMed ID: 14415455
[No Abstract] [Full Text] [Related]
15. [Treatment of coronary insufficiency with Persantin].
RIEGLER E
Wien Z Inn Med; 1961 Mar; 42():140-2. PubMed ID: 13741533
[No Abstract] [Full Text] [Related]
16. [Clinical results with a new coronary dilatator agent: persantin].
MARTINEZ RAMON E; ALCALA LLORENTE E
Med Esp; 1961 Jun; 45():470-87. PubMed ID: 13767501
[No Abstract] [Full Text] [Related]
17. Nitroglycerin and isosorbide dinitrate in coronary insufficiency.
LESLIE RE
Tex State J Med; 1961 Jun; 57():432-4. PubMed ID: 13761164
[No Abstract] [Full Text] [Related]
18. [Clinico-experimental observations on a new coronaro-dilator drug, pyrimido-pyrimidine cyclic derivative].
GRIMALDI F; ZINNARI A; GASTALDI E
Riforma Med; 1961 Dec; 75():1397-402. PubMed ID: 13901941
[No Abstract] [Full Text] [Related]
19. [On heart therapy with Persantin].
WOLF H
Wien Med Wochenschr; 1961 May; 111():357-61. PubMed ID: 13786276
[No Abstract] [Full Text] [Related]
20. The clinical effects of a new anti-anginal agent, prenylamine ("Segontin").
BAUMGARTEN A
Med J Aust; 1962 Mar; 49(1)():429-31. PubMed ID: 13865947
[No Abstract] [Full Text] [Related]
[Next] [New Search]
